エピソード

  • What's in a Name? The Journey from PCOS to PMOS

    What's in a Name? The Journey from PCOS to PMOS
    2026/10/21
    Anuja Dokras, MD, MHCI, PhD, joins Emily O'Brien and new co-host Daniel Edmonston to explain why PCOS is now PMOS, polyendocrine metabolic ovarian syndrome. She traces the global effort behind the new name and how it could reduce stigma, improve frontline care, and open doors to new research funding. https://dcri.org/blog/s3-ep-4-whats-name-journey-pcos-pmos
    続きを読む 一部表示
    33 分
  • Beyond the Headlines: AI, Lp(a), Faster Trials, and the Future of Research Funding

    Beyond the Headlines: AI, Lp(a), Faster Trials, and the Future of Research Funding
    2026/10/07
    Hosts Manesh Patel and Emily O'Brien look past the headlines on Novartis' Lp(a) drug trial results, AI agents in medicine, the FDA's Operation Trailblazer to speed up clinical trials, Dolly Parton's support for COVID research, and the case for steady NIH funding. https://dcri.org/blog/s3-ep-3-beyond-headlines
    続きを読む 一部表示
    26 分
  • The Critical Filling: 30 Years with Harrington, Peterson & Curtis

    The Critical Filling: 30 Years with Harrington, Peterson & Curtis
    2026/09/23
    Three former DCRI executive directors, Bob Harrington, Eric Peterson, and Lesley Curtis, join Beyond the Endpoint for part two of the institute's 30th anniversary series. They reflect on growth, crisis, inconvenient truths, and the culture they believe will carry DCRI through whatever comes next. https://dcri.org/blog/s3-ep-2-critical-filling-30-years-harrington-peterson-curtis
    続きを読む 一部表示
    36 分
  • The Foundation & the Future: 30 Years with Califf & Hernandez

    The Foundation & the Future: 30 Years with Califf & Hernandez
    2026/09/09
    To mark DCRI's 30th anniversary, this first episode in a two-part series features founding director Robert Califf and current Executive Director Adrian Hernandez as they look back at the institute's evolution and ahead to its future. Part two arrives Sept. 23. https://dcri.org/blog/s3-ep-1-foundation-future-30-years-califf-hernandez
    続きを読む 一部表示
    36 分
  • Beyond the Headlines: PMDD and Antihistamines, Real-Time FDA Study Monitoring Using Al, and More!

    Beyond the Headlines: PMDD and Antihistamines, Real-Time FDA Study Monitoring Using Al, and More!
    2026/05/13
    In this Beyond the Headlines episode, we examine the FDA's push for real-time clinical trial data, an executive order making psychedelic research a federal priority, advances in CAR T-cell therapy for autoimmune conditions, and viral claims about antihistamines as a treatment for premenstrual dysphoric disorder. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-16-beyond-headlines
    続きを読む 一部表示
    25 分
  • The COPD Gap: Diagnosis, Treatment, and Access

    The COPD Gap: Diagnosis, Treatment, and Access
    2026/04/22
    COPD is the third leading cause of death worldwide. Yet the disease remains underdiagnosed and underfunded. Host Emily O'Brien and pulmonologist Chris Mosher discuss stigma, funding disparities, barriers to care, and promising research that's bringing new hope to patients. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-15-copd-gap-diagnosis-treatment-and-access
    続きを読む 一部表示
    35 分
  • Hard Habits: What Kidney Stones Teach Us About Behavior Change

    Hard Habits: What Kidney Stones Teach Us About Behavior Change
    2026/04/08
    Why is it so hard to change our behavior, even when we know what we should be doing? Host Emily O'Brien sits down with urologist and DCRI faculty member Dr. Chuck Scales to discuss the science of behavior change and surprising findings from the PUSH trial, the largest kidney stone prevention trial to date. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-14-hard-habits-what-kidney-stones-teach-us-about-behavior-change
    続きを読む 一部表示
    24 分